Overview

Sufficient Chemotherapy Combine With Maintenance Chemotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma

Status:
Not yet recruiting

Trial end date:
2023-06-01

Target enrollment:

Participant gender:

Summary

This study is a randomized, phase II, prospective, multicenter clinical trial to evaluate the efficacy and safety of sufficient chemoradiotherapy plus oral capecitabine/S-1 for 1 year in the treatment of oligometastatic Nasopharyngeal Carcinoma

Phase:

Phase 2

Details

Lead Sponsor:

Fujian Cancer Hospital

Collaborators:

Jiangxi Provincial Cancer Hospital
Zhejiang Cancer Hospital

Treatments:

Capecitabine